PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

On April 27, 2017, the Compensation Committee of the Board of
Directors of ProPhase Labs, Inc. (the Company), after consulting
with its compensation consultant, granted a discretionary cash
bonus of $650,000 to Ted Karkus, the Company’s Chairman and
Chief Executive Officer, in recognition of his efforts related to
the sale of substantially all of the Companys assets, comprised
of the intellectual property and other assets related to the
Companys Cold-EEZE brand and product line, to Mylan N.V.


About PROPHASE LABS, INC. (NASDAQ:PRPH)

ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a range of homeopathic and health products. The Company is also engaged in the research and development of over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. It is engaged in manufacturing, distributing, marketing and sale of OTC cold remedy products to consumers through national chain, regional, specialty and local retail stores. It also manufactures, markets and distributes an organic cough drop and a Vitamin C supplement, Organix, and performs contract manufacturing services of cough drop, dietary supplements, and other OTC cold remedy products for third parties. Its product pipeline includes Cold-EEZE Cold Remedy QuickMelts and Cold-EEZE Cold Remedy Oral Spray. It also produces Legendz XL for sexual health, Triple Edge XL, which is a daily energy booster plus testosterone support, and Super ProstaFlow Plus for prostate and urinary health.

PROPHASE LABS, INC. (NASDAQ:PRPH) Recent Trading Information

PROPHASE LABS, INC. (NASDAQ:PRPH) closed its last trading session down -0.01 at 1.98 with 2,634 shares trading hands.